查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1870008

过敏诊断和治疗市场规模、份额和趋势分析报告：按类型、过敏原类型、检测类型、地区和细分市场预测（2025-2033 年）

Allergy Diagnostics And Therapeutics Market Size, Share & Trends Analysis Report By Type (Diagnostics and Therapeutics), By Allergen Type, By Test Type, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

过敏诊断和治疗市场摘要

2024年全球过敏诊断和治疗市场规模估计为344.2亿美元，预计2033年将达到780亿美元。

预计从 2025 年到 2033 年，该市场将以 9.7% 的复合年增长率成长。市场的主要驱动因素包括过敏症发病率的上升、技术进步和新产品的推出，以及免疫疗法药物的高普及率。

根据全球过敏和呼吸道患者平台2022年11月发布的报告，目前约有30-40%的人患有一种或多种过敏症，且过去二十年来过敏症患者人数呈上升趋势。此外，生活方式的改变和污染的加剧是导致过敏性疾病增加的主要因素。预计在预测期内，治疗手段先进的药物，特别是免疫疗法，将满足患者未被满足的需求，从而推动市场成长。例如，2024年2月，美国食品药物管理局（FDA）批准了儿童（奥马珠单抗）注射剂，这是一种免疫球蛋白E（IgE）介导的食物过敏治疗药物，用于减少某些成人和1岁及以上儿童在意外接触多种食物后可能发生的过敏反应（I型），包括降低过敏性休克的风险。 Omalizumab旨在重复使用以降低过敏反应的风险，但未核准核准即时紧急治疗过敏反应，包括过敏性休克。

过敏性疾病盛行率的上升是推动预测期内抗过敏药物市场成长的关键因素之一。慢性呼吸系统疾病的高风险因素包括室内外空气污染暴露增加以及职业暴露。由于工业活动和都市化导致环境污染物暴露增加，城市地区的过敏症盛行率远高于都市区。

根据世界卫生组织（世卫组织）2024年1月发布的统计数据，美国约有四分之一的儿童和三分之一的成年人患有季节性过敏症。美国约有6%的儿童和成人患有食物过敏症，其中黑人、亚裔和西班牙裔族群的盛行率最高。同样，根据美国气喘和过敏基金会的数据，截至2021年，美国约有8,100万人被诊断出患有季节性过敏性鼻炎，约占成年人的26%和儿童的19%。

预计在预测期内，体外诊断（IVD）需求的成长将推动过敏诊断和治疗市场的发展。体外血液检测用于诊断食物、吸入物、皮肤和药物过敏。这些检测具有微创、经济高效、操作简便等诸多优势，预计将为市场带来盈利的成长前景。此外，低成本、高效的过敏检测体外诊断技术的开发、检查室自动化程度的提高以及试剂租赁协议的增加，预计都将在未来几年内促进市场扩张。

目录

第一章 过敏诊断和治疗市场：调查方法和范围

2. 过敏诊断与治疗市场：执行摘要

  • 市场概述
  • 产品概览
  • 过敏原类型概览
  • 类型简介
  • 竞争格局概览

3. 过敏诊断和治疗市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 过敏症发生率上升
    • 技术进步和新产品发布
    • 免疫疗法药物的高采用率
  • 市场限制因素分析
    • 高昂的技术成本导致开发中国家的技术普及率和采用率较低。
    • 缺乏过敏原标准化
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第四章 过敏诊断和治疗市场：按类型分類的估计和趋势分析

  • 过敏诊断与治疗市场：波动分析
  • 诊断
  • 装置
  • 消耗品
  • 服务
  • 治疗药物
  • 抗组织胺药
  • 鼻腔减充血剂
  • 皮质类固醇
  • 肥大细胞稳定剂
  • 白三烯抑制剂
  • 鼻用抗胆碱能药物
  • 免疫调节药物
  • 肾上腺素
  • 免疫疗法

第五章 过敏诊断与治疗市场：依过敏原类型分類的估算与趋势分析

  • 过敏诊断与治疗市场：波动分析
  • 食物
  • 乳製品
  • 家禽产品
  • 坚果
  • 花生
  • 贝类
  • 小麦
  • 大豆
  • 其他食物过敏原
  • 吸入
  • 药品
  • 其他过敏原类型

第六章 过敏诊断和治疗市场：按检测类型分類的估算和趋势分析

  • 过敏诊断与治疗市场：波动分析
  • 体内试验
  • 皮肤点刺试验
  • 皮内试验
  • 斑贴测试
  • 体外试验

7. 过敏诊断与治疗市场：区域业务分析

  • 区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第八章 竞争情势

  • 公司分类
  • 策略规划
    • 新产品上市
    • 伙伴关係
    • 获得
    • 合作
    • 资金筹措
  • 主要企业市占率分析，2024 年
  • 公司热力图分析
  • 公司简介
    • R-Biopharm AG
    • EUROIMMUN Medizinische Labordiagnostika AG（PerkinElmer, Inc.）
    • DASIT Group SPA
    • AESKU.GROUP GmbH
    • bioMerieux
    • Danaher
    • AbbVie, Inc
    • Thermo Fisher Scientific, Inc
    • Stallergenes Greer
    • Minaris Medical America, Inc.
    • Siemens Healthcare GmbH
    • Omega Diagnostics Group PLC
    • HYCOR Biomedical
    • Lincoln Diagnostics, Inc.
    • Alcon
    • HOB Biotech Group Corp., Ltd.
    • AbbVie Inc.
    • Allergy Therapeutics
    • Sanofi
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • GSK plc
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co., Inc.
    • Astellas Pharma Inc.
Product Code: 978-1-68038-701-8

Allergy Diagnostics And Therapeutics Market Summary

The global allergy diagnostics and therapeutics market size was estimated at USD 34.42 billion in 2024 and is projected to reach USD 78.00 billion by 2033, growing at a CAGR of 9.7% from 2025 to 2033. Some of the major factors driving the market are rising incidence of allergies, advancements in technology and launch of new products, and high adoption of immunotherapy drugs.

In November 2022, the Global Allergy and Airways Patient Platform reported that approximately 30-40% of people today have one or more allergies, and the number of people with allergies has been increasing over the past 20 years. Furthermore, changing lifestyle and growing pollution are some of the key factors contributing to the increasing incidence of allergic conditions. The introduction of therapeutically advanced drugs namely immunotherapy, which solves unmet patient needs, is expected to boost market growth over the forecast period. For instance, in February 2024, the U.S. Food and Drug Administration approved Xolair (omalizumab) injection for immunoglobulin E-mediated food allergy in certain adults and children 1 year or older for the reduction of allergic reactions (Type I), including reducing the risk of anaphylaxis, that may occur with accidental exposure due to more than one food. Also, Xolair is intended for repeated use to reduce the risk of allergic reactions and is not approved for the immediate emergency treatment of allergic reactions, including anaphylaxis.

The rising prevalence of allergies is one of the important reasons driving the growth of the allergy therapeutics market over the predicted period. High risk factors for chronic respiratory disorders include increased exposure to outdoor and indoor air pollution, as well as occupational exposure. Allergies are far more common in cities than in rural areas, owing to increased exposure to environmental contaminants due to industrial activity and urbanization.

According to statistics published by WHO in January 2024, around 1 in 4 children and 1 in 3 adults have a seasonal allergy in the U.S. Nearly 6% of children and adults in the U.S. suffer from a food allergy, with the rate being highest among black, Asian, and Hispanic individuals. Similarly, as per data from the Asthma and Allergy Foundation of America, in 2021, in the U.S., about 81 million people were diagnosed with seasonal allergic rhinitis, representing around 26% affected adults and 19% affected children.

Increasing demand for IVD testing is likely to drive the allergy diagnostics and therapeutics market over the forecast period. In vitro blood tests are used to diagnose food, inhalation, skin, and medication allergies. These tests have several advantages, including the fact that they are minimally invasive, cost-effective, and user-friendly, which is expected to provide profitable growth prospects in this market. Furthermore, the development of low-cost and effective in vitro diagnostic tests for allergy detection, increased lab automation, and an increase in reagent rental agreements are all projected to contribute to market expansion in the future years.

Global Allergy Diagnostics and Therapeutic Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2030. For this report, Grand View Research has segmented the global allergy diagnostics & therapeutics market based on type, allergen type, test type, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostics
    • Instruments
    • Consumables
    • Services
  • Therapeutics
    • Antihistamines
    • Decongestants
    • Corticosteroids
    • Mast Cell Stabilizers
    • Leukotriene Inhibitors
    • Nasal Anti-cholinergic
    • Immuno-modulators
    • Epinephrine
    • Immunotherapy
  • Allergen Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Food
    • Dairy Products
    • Poultry Product
    • Tree Nuts
    • Peanuts
    • Shellfish
    • Wheat
    • Soy
    • Other Food Allergens
  • Inhaled
  • Drug
  • Others allergen types
  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • In Vivo Tests
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In Vitro Tests
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Allergy Diagnostics and Therapeutics Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Method
      • 1.1.1.2. Allergen Type Segment
      • 1.1.1.3. Test Type Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Allergy Diagnostics and Therapeutics Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Product Snapshot
  • 2.3. Allergen Type Snapshot
  • 2.4. Type Snapshot
  • 2.5. Competitive Landscape Snapshot

Chapter 3. Allergy Diagnostics and Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising incidence of allergies
    • 3.4.2. Advancements in technology and launch of new products
    • 3.4.3. High adoption of immunotherapy drugs
  • 3.5. Market Restraint Analysis
    • 3.5.1. Low adoption and penetration in developing countries due to the high cost of technology
    • 3.5.2. Lack of allergen standardization
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Allergy Diagnostics and Therapeutics Market: Type Estimates & Trend Analysis

  • 4.1. Allergy Diagnostics and Therapeutics Market: Test Method Movement Analysis
  • 4.2. Diagnostics
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Instruments
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Therapeutics
    • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Antihistamines
    • 4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Decongestants
    • 4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Corticosteroids
    • 4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Mast Cell Stabilizers
    • 4.10.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Leukotriene Inhibitors
    • 4.11.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.12. Nasal Anti-cholinergic
    • 4.12.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.13. Immuno-modulators
    • 4.13.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.14. Epinephrine
    • 4.14.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.15. Immunotherapy
    • 4.15.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Allergy Diagnostics and Therapeutics Market: Allergen Type Estimates & Trend Analysis

  • 5.1. Allergy Diagnostics and Therapeutics Market: Mode Movement Analysis
  • 5.2. Food
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Dairy Products
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Poultry Product
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Tree Nuts
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Peanuts
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Shellfish
    • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Wheat
    • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Soy
    • 5.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Other Food Allergens
    • 5.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.11. Inhaled
    • 5.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.12. Drug
    • 5.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.13. Others allergen types
    • 5.13.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Allergy Diagnostics and Therapeutics Market: Test Type Estimates & Trend Analysis

  • 6.1. Allergy Diagnostics and Therapeutics Market: Type Movement Analysis
  • 6.2. In Vivo tests
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Skin Prick Test
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Intradermal Test
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Patch Test
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. In Vitro tests
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Allergy Diagnostics and Therapeutics Market: Regional Business Analysis

  • 7.1. Regional Market Snapshot
  • 7.2. North America
    • 7.2.1. North America Allergy Diagnostics and Therapeutics Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.2.2.2. Key Country Dynamics
      • 7.2.2.3. Regulatory Framework
      • 7.2.2.4. Reimbursement Scenario
      • 7.2.2.5. Competitive Scenario
    • 7.2.3. Canada
      • 7.2.3.1. Canada Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.2.3.2. Key Country Dynamics
      • 7.2.3.3. Regulatory Framework
      • 7.2.3.4. Reimbursement Scenario
      • 7.2.3.5. Competitive Scenario
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.2.4.2. Key Country Dynamics
      • 7.2.4.3. Regulatory Framework
      • 7.2.4.4. Reimbursement Scenario
      • 7.2.4.5. Competitive Scenario
  • 7.3. Europe
    • 7.3.1. Europe Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.3.2.2. Key Country Dynamics
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. Competitive Scenario
    • 7.3.3. Germany
      • 7.3.3.1. Germany Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.3.3.2. Key Country Dynamics
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Competitive Scenario
    • 7.3.4. Spain
      • 7.3.4.1. Spain Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.3.4.2. Key Country Dynamics
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Competitive Scenario
    • 7.3.5. France
      • 7.3.5.1. France Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.3.5.2. Key Country Dynamics
      • 7.3.5.3. Regulatory Framework
      • 7.3.5.4. Reimbursement Scenario
      • 7.3.5.5. Competitive Scenario
    • 7.3.6. Italy
      • 7.3.6.1. Italy Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.3.6.2. Key Country Dynamics
      • 7.3.6.3. Regulatory Framework
      • 7.3.6.4. Reimbursement Scenario
      • 7.3.6.5. Competitive Scenario
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.3.7.2. Key Country Dynamics
      • 7.3.7.3. Regulatory Framework
      • 7.3.7.4. Reimbursement Scenario
      • 7.3.7.5. Competitive Scenario
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.3.8.2. Key Country Dynamics
      • 7.3.8.3. Regulatory Framework
      • 7.3.8.4. Reimbursement Scenario
      • 7.3.8.5. Competitive Scenario
    • 7.3.9. Norway
      • 7.3.9.1. Norway Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.3.9.2. Key Country Dynamics
      • 7.3.9.3. Regulatory Framework
      • 7.3.9.4. Reimbursement Scenario
      • 7.3.9.5. Competitive Scenario
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.4.2.2. Key Country Dynamics
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. Competitive Scenario
    • 7.4.3. China
      • 7.4.3.1. China Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.4.3.2. Key Country Dynamics
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Competitive Scenario
    • 7.4.4. India
      • 7.4.4.1. India Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.4.4.2. Key Country Dynamics
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. Competitive Scenario
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.4.5.2. Key Country Dynamics
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Competitive Scenario
    • 7.4.6. Thailand
      • 7.4.6.1. Thailand Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.4.6.2. Key Country Dynamics
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Competitive Scenario
    • 7.4.7. Australia
      • 7.4.7.1. Australia Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.4.7.2. Key Country Dynamics
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Competitive Scenario
  • 7.5. Latin America
    • 7.5.1. Latin America Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.5.2.2. Key Country Dynamics
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Competitive Scenario
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.5.3.2. Key Country Dynamics
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. Competitive Scenario
  • 7.6. MEA
    • 7.6.1. MEA Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.6.2.2. Key Country Dynamics
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Competitive Scenario
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.6.3.2. Key Country Dynamics
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Competitive Scenario
    • 7.6.4. UAE
      • 7.6.4.1. UAE Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.6.4.2. Key Country Dynamics
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement Scenario
      • 7.6.4.5. Competitive Scenario
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Allergy Diagnostics and Therapeutics Market, 2021 - 2033 (USD Million)
      • 7.6.5.2. Key Country Dynamics
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement Scenario
      • 7.6.5.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. R-Biopharm AG
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.)
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. DASIT Group SPA
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. AESKU.GROUP GmbH
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. bioMerieux
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Danaher
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. AbbVie, Inc
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Thermo Fisher Scientific, Inc
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Stallergenes Greer
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Minaris Medical America, Inc.
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives
    • 8.5.11. Siemens Healthcare GmbH
      • 8.5.11.1. Overview
      • 8.5.11.2. Financial Performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic Initiatives
    • 8.5.12. Omega Diagnostics Group PLC
      • 8.5.12.1. Overview
      • 8.5.12.2. Financial Performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic Initiatives
    • 8.5.13. HYCOR Biomedical
      • 8.5.13.1. Overview
      • 8.5.13.2. Financial Performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic Initiatives
    • 8.5.14. Lincoln Diagnostics, Inc.
      • 8.5.14.1. Overview
      • 8.5.14.2. Financial Performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic Initiatives
    • 8.5.15. Alcon
      • 8.5.15.1. Overview
      • 8.5.15.2. Financial Performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic Initiatives
    • 8.5.16. HOB Biotech Group Corp., Ltd.
      • 8.5.16.1. Overview
      • 8.5.16.2. Financial Performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic Initiatives
    • 8.5.17. AbbVie Inc.
      • 8.5.17.1. Overview
      • 8.5.17.2. Financial Performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic Initiatives
    • 8.5.18. Allergy Therapeutics
      • 8.5.18.1. Overview
      • 8.5.18.2. Financial Performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic Initiatives
    • 8.5.19. Sanofi
      • 8.5.19.1. Overview
      • 8.5.19.2. Financial Performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic Initiatives
    • 8.5.20. Pfizer Inc.
      • 8.5.20.1. Overview
      • 8.5.20.2. Financial Performance
      • 8.5.20.3. Product Benchmarking
      • 8.5.20.4. Strategic Initiatives
    • 8.5.21. Teva Pharmaceutical Industries Ltd.
      • 8.5.21.1. Overview
      • 8.5.21.2. Financial Performance
      • 8.5.21.3. Product Benchmarking
      • 8.5.21.4. Strategic Initiatives
    • 8.5.22. Sun Pharmaceutical Industries Ltd.
      • 8.5.22.1. Overview
      • 8.5.22.2. Financial Performance
      • 8.5.22.3. Product Benchmarking
      • 8.5.22.4. Strategic Initiatives
    • 8.5.23. GSK plc
      • 8.5.23.1. Overview
      • 8.5.23.2. Financial Performance
      • 8.5.23.3. Product Benchmarking
      • 8.5.23.4. Strategic Initiatives
    • 8.5.24. F. Hoffmann-La Roche Ltd.
      • 8.5.24.1. Overview
      • 8.5.24.2. Financial Performance
      • 8.5.24.3. Product Benchmarking
      • 8.5.24.4. Strategic Initiatives
    • 8.5.25. Merck & Co., Inc.
      • 8.5.25.1. Overview
      • 8.5.25.2. Financial Performance
      • 8.5.25.3. Product Benchmarking
      • 8.5.25.4. Strategic Initiatives
    • 8.5.26. Astellas Pharma Inc.
      • 8.5.26.1. Overview
      • 8.5.26.2. Financial Performance
      • 8.5.26.3. Product Benchmarking
      • 8.5.26.4. Strategic Initiatives

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviation
  • TABLE 3 Global Allergy Diagnostics & Therapeutics Market, By Region, 2021 - 2033 (USD Million)
  • TABLE 4 Global Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 5 Global Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 6 Global Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 7 North America Allergy Diagnostics & Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • TABLE 8 North America Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 9 North America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 10 North America Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 11 U.S. Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 12 U.S. Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 13 U.S. Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 14 Canada Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 15 Canada Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 16 Canada Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 17 Europe Allergy Diagnostics & Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • TABLE 18 Europe Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 19 Europe Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 20 Europe Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 21 UK Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 22 UK Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 23 UK Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 24 Germany Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 25 Germany Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 26 Germany Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 27 France Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 28 France Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 29 France Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 30 Italy Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 31 Italy Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 32 Italy Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 33 Spain Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 34 Spain Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 35 Spain Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 36 Denmark Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 37 Denmark Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 38 Denmark Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 39 Sweden Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 40 Sweden Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 41 Sweden Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 42 Norway Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 43 Norway Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 44 Norway Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 45 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • TABLE 46 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 47 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 48 Asia Pacific Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 49 Japan Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 50 Japan Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 51 Japan Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 52 China Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 53 China Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 54 China Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 55 India Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 56 India Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 57 India Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 58 Australia Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 59 Australia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 60 Australia Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 61 South Korea Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 62 South Korea Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 63 South Korea Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 64 Thailand Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 65 Thailand Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 66 Thailand Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 67 Latin America Allergy Diagnostics & Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • TABLE 68 Latin America Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 69 Latin America Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 70 Latin America Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 71 Brazil Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 72 Brazil Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 73 Brazil Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 74 Mexico Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 75 Mexico Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 76 Mexico Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 77 Argentina Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 78 Argentina Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 79 MEA Allergy Diagnostics & Therapeutics Market, By Country, 2021 - 2033 (USD Million)
  • TABLE 80 MEA Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 81 MEA Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 82 MEA Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 83 South Africa Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 84 South Africa Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 85 South Africa Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 86 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 87 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 88 Saudi Arabia Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 89 UAE Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 90 UAE Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 91 UAE Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)
  • TABLE 92 Kuwait Allergy Diagnostics & Therapeutics Market, By Type, 2021 - 2033 (USD Million)
  • TABLE 93 Kuwait Allergy Diagnostics & Therapeutics Market, By Allergen type, 2021 - 2033 (USD Million)
  • TABLE 94 Kuwait Allergy Diagnostics & Therapeutics Market, By Test Type, 2021 - 2033 (USD Million)

List of Figures

  • FIG. 1 Allergy Diagnostics & Therapeutics Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment.
  • FIG. 8 Market formulation & validation
  • FIG. 9 Allergy Diagnostics & Therapeutics Market snapshot
  • FIG. 10 Parent market outlook
  • FIG. 11 Related/ancillary market outlook.
  • FIG. 12 Penetration and growth prospect mapping
  • FIG. 13 Allergy Diagnostics & Therapeutics Market driver impact
  • FIG. 14 Allergy Diagnostics & Therapeutics Market restraint impact
  • FIG. 15 SWOT analysis, by factor (political & legal, economic, and technological)
  • FIG. 16 Industry Analysis - Porter's
  • FIG. 17 Strategy mapping
  • FIG. 18 Allergy Diagnostics & Therapeutics Market: Type outlook and key takeaways
  • FIG. 19 Allergy Diagnostics & Therapeutics Market: Type movement analysis & market share 2024 & 2030
  • FIG. 20 Diagnostics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 21 Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 22 Instruments market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 23 Consumable market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 24 Services market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 25 Antihistamines Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 26 Angiotensin 2 Receptor Blockers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 27 Decongestants Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 28 Corticosteroids Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 29 Mast Cell Stabilizers Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 30 Leukotriene Inhibitors Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 31 Nasal Anti-cholinergic Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 32 Immuno-modulators Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 33 Epinephrine Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 34 Immunotherapy Allergy Diagnostics & Therapeutics Market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 35 Allergy Diagnostics & Therapeutics Market: Allergen Type outlook and key takeaways
  • FIG. 36 Allergy Diagnostics & Therapeutics Market: Allergen Type movement analysis & market share 2024 & 2030
  • FIG. 37 Food market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 38 Dairy Products market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 39 Poultry Product market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 40 Tree Nuts market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 41 Peanuts market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 42 Shellfish market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 43 Wheat market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 44 Soy market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 45 Other Food Allergens market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 46 Inhaled market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 47 Drug market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 48 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 49 Allergy Diagnostics & Therapeutics Market: Test Type outlook and key takeaways
  • FIG. 50 Allergy Diagnostics & Therapeutics Market: Test Type movement analysis & market share 2024 & 2030
  • FIG. 51 In vivo Test market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 52 Skin Prick Test market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 53 Intradermal Test market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 54 Patch Test market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 55 In Vitro Test market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 56 Regional marketplace: Key takeaways
  • FIG. 57 Global Allergy Diagnostics and Therapeutics Market: Regional movement analysis
  • FIG. 58 U.S. market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 59 Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 60 Europe market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 61 UK market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 62 Germany market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 63 France market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 64 Italy market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 65 Spain market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 66 Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 67 Sweden market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 68 Norway market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 69 Asia-Pacific market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 70 Japan market estimates and forecast, 2021 - 2033(USD Million)
  • FIG. 71 China market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 72 India market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 73 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 74 Australia market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 75 Thailand market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 76 Latin America market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 77 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 78 Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 79 Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 80 MEA market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 81 South Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 82 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 83 UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 84 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
  • FIG. 85 Strategy framework